Similar to our previous study of chronic myeloid leukemia (CML), we found higher miR‐126 levels in more primitive subsets (CD34+CD38–) of MDS as compared to mature subsets (CD34+CD38+). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.